Fellowship & Membership

  • European Society of Medical Oncology (ESMO).
  • American Society of Clinical Oncology (ASCO).
  • Field of Expertise

  • Immunotherapy
  • Targeted Therapy
  • Personalized medicine and molecular Oncology
  • Management of Solid Malignancies like breast cancer, lung cancer, gynaecological malignancies, urogenital malignancies, gastrointestinal malignancies.
  • Management of hemato-lymphoid malignancies like leukemia, lymphoma, myeloma.
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Talks & Publications

  • Best Poster Presentation at the 1st Annual Meeting of the Indian Society for Blood and Bone Marrow Transplantation held at CMC Vellore in March 2020.
  • Research on Neutrophil-Lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors presented as a poster at the prestigious ESMO (European society of Medical Oncology), immuno-oncology meet in Geneva 2019.
  • Best Oral paper award at 41st ICON held in Ahmedabad in September 2019 for the topic significance of neutrophil-lymphocyte ratio on prognosis inpatients of metastatic renal cell carcinoma & non-small cell lung cancer treated with immunotherapy.
  • Second prize for best oral presentation for research on Management of toxicities associated with immune checkpoint inhibitors; a single centre experience at IO-SICON 2019 conducted by Tata Memorial Hospital Mumbai in February 2019.
  • Top 5 Oral Presentation in Lymphocon 2019 Organized by Kiwai Memorial Institute of Oncology for a paper on management of relapsed/refractory Hodgkins lymphoma; Experience with autologous stem cell transplant (ASCT) and impact.

    Languages Spoken

  • English
  • Kannada
  • Hindi
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO).
  • American Society of Clinical Oncology (ASCO).
  • Field of Expertise

  • Immunotherapy
  • Targeted Therapy
  • Personalized medicine and molecular Oncology
  • Management of Solid Malignancies like breast cancer, lung cancer, gynaecological malignancies, urogenital malignancies, gastrointestinal malignancies.
  • Management of hemato-lymphoid malignancies like leukemia, lymphoma, myeloma.
  • Talks & Publications

  • Best Poster Presentation at the 1st Annual Meeting of the Indian Society for Blood and Bone Marrow Transplantation held at CMC Vellore in March 2020.
  • Research on Neutrophil-Lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors presented as a poster at the prestigious ESMO (European society of Medical Oncology), immuno-oncology meet in Geneva 2019.
  • Best Oral paper award at 41st ICON held in Ahmedabad in September 2019 for the topic significance of neutrophil-lymphocyte ratio on prognosis inpatients of metastatic renal cell carcinoma & non-small cell lung cancer treated with immunotherapy.
  • Second prize for best oral presentation for research on Management of toxicities associated with immune checkpoint inhibitors; a single centre experience at IO-SICON 2019 conducted by Tata Memorial Hospital Mumbai in February 2019.
  • Top 5 Oral Presentation in Lymphocon 2019 Organized by Kiwai Memorial Institute of Oncology for a paper on management of relapsed/refractory Hodgkins lymphoma; Experience with autologous stem cell transplant (ASCT) and impact.

    Field of Expertise

  • Immunotherapy
  • Targeted Therapy
  • Personalized medicine and molecular Oncology
  • Management of Solid Malignancies like breast cancer, lung cancer, gynaecological malignancies, urogenital malignancies, gastrointestinal malignancies.
  • Management of hemato-lymphoid malignancies like leukemia, lymphoma, myeloma.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO).
  • American Society of Clinical Oncology (ASCO).
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Talks & Publications

  • Best Poster Presentation at the 1st Annual Meeting of the Indian Society for Blood and Bone Marrow Transplantation held at CMC Vellore in March 2020.
  • Research on Neutrophil-Lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors presented as a poster at the prestigious ESMO (European society of Medical Oncology), immuno-oncology meet in Geneva 2019.
  • Best Oral paper award at 41st ICON held in Ahmedabad in September 2019 for the topic significance of neutrophil-lymphocyte ratio on prognosis inpatients of metastatic renal cell carcinoma & non-small cell lung cancer treated with immunotherapy.
  • Second prize for best oral presentation for research on Management of toxicities associated with immune checkpoint inhibitors; a single centre experience at IO-SICON 2019 conducted by Tata Memorial Hospital Mumbai in February 2019.
  • Top 5 Oral Presentation in Lymphocon 2019 Organized by Kiwai Memorial Institute of Oncology for a paper on management of relapsed/refractory Hodgkins lymphoma; Experience with autologous stem cell transplant (ASCT) and impact.

    Talks & Publications

  • Best Poster Presentation at the 1st Annual Meeting of the Indian Society for Blood and Bone Marrow Transplantation held at CMC Vellore in March 2020.
  • Research on Neutrophil-Lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors presented as a poster at the prestigious ESMO (European society of Medical Oncology), immuno-oncology meet in Geneva 2019.
  • Best Oral paper award at 41st ICON held in Ahmedabad in September 2019 for the topic significance of neutrophil-lymphocyte ratio on prognosis inpatients of metastatic renal cell carcinoma & non-small cell lung cancer treated with immunotherapy.
  • Second prize for best oral presentation for research on Management of toxicities associated with immune checkpoint inhibitors; a single centre experience at IO-SICON 2019 conducted by Tata Memorial Hospital Mumbai in February 2019.
  • Top 5 Oral Presentation in Lymphocon 2019 Organized by Kiwai Memorial Institute of Oncology for a paper on management of relapsed/refractory Hodgkins lymphoma; Experience with autologous stem cell transplant (ASCT) and impact.
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO).
  • American Society of Clinical Oncology (ASCO).
  • Field of Expertise

  • Immunotherapy
  • Targeted Therapy
  • Personalized medicine and molecular Oncology
  • Management of Solid Malignancies like breast cancer, lung cancer, gynaecological malignancies, urogenital malignancies, gastrointestinal malignancies.
  • Management of hemato-lymphoid malignancies like leukemia, lymphoma, myeloma.
  • Languages Spoken

  • English
  • Kannada
  • Hindi
Appointment
Health Check
Home Care
Contact Us
Write to COO
review icon Review Us
Call Us